New hope for painful skin condition: experimental drug enters mid-stage trial

NCT ID NCT07244510

Recruiting now Disease control Sponsor: Sinocelltech Ltd. Source: ClinicalTrials.gov ↗

First seen Dec 08, 2025 · Last updated Jun 16, 2026 · Updated 28 times

Summary

This study tests an experimental drug called SCT650C in 60 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing boils and tunnels. The goal is to see if the drug can reduce abscesses and inflammation by at least 75% after 16 weeks. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor their doctors will know which they receive.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA (HS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ondokuz Mayis University Medical Faculty
RECRUITING

Samsun, Turkey, 55200, Turkey (Türkiye)

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA (HS)